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Recent molecular diagnostic methods have significantly improved the diagnosis of viral
pneumonia in intensive care units (ICUs). It has been observed that 222G/N changes in the
HA gene of H1N1pdm09 are associated with increased lower respiratory tract (LRT) replica-
tion and worse clinical outcome. In the present study, the frequency of respiratory viruses
was assessed in respiratory samples from 88 patients admitted to 16 ICUs during the 2014–
2015 winter-spring season in Lombardy. Sixty-nine out of 88 (78.4%) patients were positive
for a respiratory viral infection at admission. Of these, 57/69 (82.6%) were positive for influ-
enza A (41 A/H1N1pdm09 and 15 A/H3N2), 8/69 (11.6%) for HRV, 2/69 (2.9%) for RSV and
2/69 (2.9%) for influenza B. Phylogenetic analysis of influenza A/H1N1pdm09 strains from
28/41 ICU-patients and 21 patients with mild respiratory syndrome not requiring hospitaliza-
tion, showed the clear predominance of subgroup 6B strains. The median influenza A load
in LRT samples of ICU patients was higher than that observed in the upper respiratory tract
(URT) (p<0.05). Overall, a greater number of H1N1pdm09 virus variants were observed
using next generation sequencing on partial HA sequences (codons 180–286) in clinical
samples from the LRT as compared to URT. In addition, 222G/N/A mutations were
observed in 30% of LRT samples from ICU patients. Finally, intra-host evolution analysis
showed the presence of different dynamics of viral population in LRT of patients hospitalized
in ICU with a severe influenza infection.
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Introduction
While, severe bacterial community-acquired pneumonia is a well-known problem, severe viral
infections might be underestimated due to low awareness. On the other hand, the introduction
of molecular diagnostic methods has significantly improved the epidemiological investigation
of viral pneumonia in the ICU in recent years with increased potential for detection of a wide
array of viruses. In fact, in recent studies, viruses accounted for 20–50% of total infections in
patients admitted to the intensive care unit (ICU) with severe respiratory distress [1–4]. In
addition, the emergence of new respiratory viruses such as human coronavirus (hCoV) SARS,
hCoV-MERS and influenza A/H1N1pdm09, has further underscored the role of viruses in
severe respiratory infections. Still, the role of viral agents other than influenza such as rhinovi-
rus (HRV), parainfluenza viruses 1–4 (hPIV1-4), respiratory syncytial virus (RSV) and hCoV
which are frequently detected in respiratory samples of ICU patients, is not fully appreciated
[1,2].
During the 2014–2015 influenza season, an increased number of laboratory-confirmed influ-
enza admissions to ICUs (and deaths), as compared to previous seasons was observed in the
Northern Hemisphere [5]. In general, the emergence of inherently more virulent viruses during
the course of a given season should not be overlooked [6]; while, different host factors responsi-
ble for the severe outcome of influenza infection have been suggested (i.e. pregnancy and obe-
sity) [7]. More specifically as observed during the 2009 influenza virus (A/H1N1pdm09)
pandemic, only a few genetic changes may increase transmissibility, replicative efficiency and
tissue tropism range [8–12]. For instance, single amino acid changes (222G/N) in the HA gene
are associated with increased virus replication in the lower respiratory tract (LRT) and worse
clinical outcome [8–12]. However, it is still unclear how these mutations emerge, evolve, con-
solidate and/or disappear in the context of dynamic viral population changes during the
infection.
The aims of this study were: i) to describe the frequency of respiratory viruses in patients
admitted to the ICU during a winter-spring season in a multicenter prospective observational
study; ii) to monitor the presence of polymorphisms at position 222 in the HA gene of influ-
enza A/H1N1pdm09 strains and iii) to investigate the dynamics of an influenza virus popula-
tion in the LRT of ICU patients using both Sanger and next generation sequencing (NGS).
Materials and methods
Study design
From December 1 2014 to April 30 2015, nasal swabs (NS), nasopharyngeal aspirates (NPA),
bronchoalveolar lavage (BAL) and broncho aspirates (Brasp), collected from patients with
acute respiratory failure requiring ICU admission in Lombardy (10 million inhabitants),
were prospectively analyzed as part of a Regional Influenza Surveillance Plan. Analyses were
centralized at the Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia
or at the Department of Biomedical Sciences for Health, University of Milan. Severe respira-
tory syndrome was defined as acute onset (1 week) respiratory failure, with hypoxemia
(pO2/FiO2 ratio <300 mmHg while on positive end-expiratory pressure (PEEP) or noninva-
sive CPAP5 cmH2O) and bilateral opacities at chest imaging [13].
All samples positive for influenza A/H1N1pdm09 virus were analyzed for the presence of
polymorphisms at position 222 of the HA gene. In addition, a group of A/H1N1pdm09-posi-
tive patients with mild respiratory syndrome not requiring hospitalization were included in
the study as controls.
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Ethics statement
This retrospective study was performed according to the the Regional Surveillance and Pre-
paredness Plan (DGR IX/1046, 22 Dec. 2010 and DGR 5988, 30 Jun 2011) and to the guidelines
of the Institutional Review Board on the use of biological specimens for scientific purposes in
keeping with Italian law (art.13 D.Lgs 196/2003) and was approved by the Ethics Commitee of
Fondazione IRCCS Policlinico San Matteo in Pavia, Italy. Diagnostic and clinical management
of patients admitted to hospitals in the Lombardy Region with severe and moderate influenza
like illness (ILI) included prospective influenza A detection, subtyping and sequencing. The
latter two were centralized at two Regional Reference Laboratories. Mild respiratory infection
specimens were collected by sentinel practitioners and anonymously analyzed at the reference
laboratory in Milan, according to the National Surveillance Plan (Influnet). Informed consent
for Influenza A genotyping was not required since patients with severe and mild ILI were
included in the Regional diagnostic and clinical management protocol. Data were anony-
mously analyzed according to the Regional Surveillance and Preparedness Plan; while, mild
ILI samples were collected and anonymously analyzed in the framework of the National Sur-
veillance Plan (Influnet).
Respiratory virus detection and other microbiological investigations
Nucleic acids from respiratory samples were extracted using the QIAsymphony1 instrument
with the QIAsymphony1 DSP Virus/Pathogen—Midi Kit (Complex 400 protocol) according
to the manufacturer’s instructions (QIAGEN, Qiagen, Hilden, Germany). A panel of labora-
tory-developed real-time RT-PCR or real-time PCR [14,15] were used; these are able to detect
and quantify the following viruses: influenza virus A and B (including subtype determination),
HRV, hPIV3, RSV types A and B, hCoV-OC43, -229E, -NL63, and -HKU1, and human metap-
neumovirus (hMPV). Bacterial and fungal cultures were performed, with the use of standard
techniques, on quantified BAL and Brasp specimens.
HA Sanger sequencing and phylogenetic analysis
The complete influenza A/H1N1pdm09 HA gene was amplified directly from clinical speci-
mens using the SuperScriptIII One-Step RT-PCR amplification kit (Invitrogen, Carlsbad,
USA) and specific primers (available upon request). Purified PCR products were sequenced
using the BigDye Terminator Cycle-Sequencing kit (Applied Biosystems, Foster City, USA) in
an ABI Prism 3130xl Genetic Analyzer (Applied Biosystems, Foster City, USA). Sequences
were assembled using the Sequencher software, version 4.6 (Gene Codes Corporation, Ann
Arbor, USA). Nucleotide alignments were constructed using the ClustalW program embedded
in the MEGA version 5 software [16]. Phylogenetic trees were generated by means of the Maxi-
mum likelihood method with the Kimura 3-parameter as an evolutionary model using MEGA
version 5 software [16]. A bootstrap analysis with 1,000 replicates was performed. Sanger
sequences originated in this study have been submitted to GenBank database with accession
numbers KY345117-KY345168.
NGS amplicon
Primers targeting the influenza A HA gene spanning codons 180–286 were used to amplify the
region containing codon 222, as previously reported [17]. For synthesis of cDNA, the reaction
was carried out using the Transcriptor High Fidelity cDNA synthesis kit (Roche Diangnostics,
GmBH) and 5 ul of extracted RNA. Amplifications were performed using the FastStart High-
Fidelity PCR System kit (Roche Applied Science) with the following reagent mix: 10 μl of
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extracted DNA, 5 μl of 10x buffer, 0.25 μl of each primer (10 uM) HA222-for5’-CACCATC
CATCTACTAGTGCTGAC-3’and HA222-rev5’-ATAGCACCYTTGGGTGTCTG-3’, 1 μl
of PCR grade nucleotide mix (200μM each dNTP), 0.5 μl of FastStart High-Fidelity enzyme
blend (5U/μl) and 28.5 μl PCR grade water. The cycling conditions for the amplification were
as follows: 95˚C for 2 min; 45 cycles of 95˚C for 30s, 60˚C for 30s, and 72˚C for 1 min, with a
final extension cycle at 72˚C for 5 min.
Library preparation, emulsion and sequencing
Amplicons were purified with Agencourt AMPure XP magnetic beads (Beckman Coulter,
High Wycombe, UK) and quantified with the Quant-iT PicoGreen dsDNA Assay Kit (Invitro-
gen, Life Technologies, Paisley, UK) with a TBS-380 Mini-Fluorometer (Turner Biosystems,
Sunnyvale, CA). A dilution of 1×109 molecules/μl was performed for each amplicon and then
pooled in an equimolar concentration. The mixture was further purified with Agencourt
AMPure XP magnetic beads (Beckman Coulter, High Wycombe, UK) and diluted to 1×106
molecules/ul. The purified pool was clonally amplified by emulsion PCR (emPCR), following
the emPCR Amplification Manual for 454 GS Junior Titanium. A total of 500,000 enriched
beads were deposited into a PicoTitrePlate (PTP) device and sequenced using the GS Junior
454 system (Roche Diagnostics, West Sussex, UK).
Analysis of NGS data
Sequencing data were obtained as standard flowgram format (SFF) files from the GS run pro-
cessor after quality-control filtering and read trimming using the manufacturer’s default
parameters (see 454 Sequencing System software manual version 2.5). The SFF data files were
further analyzed using the GS Amplicon Variant Analyzer (AVA) version 2.7 (Roche 454 Life
Sciences, Branford, CT). The reads were trimmed using the multiplex identifiers (MIDs) for
each sample, and mapped using the reference FASTA HA sequences of the California/07/2009
strain (AY6894). The identification of variants was made using the default AVA settings. We
considered all changes whose frequency was at least 0.50% (i.e. three times the insertion error
rate) as true variability; this was the highest frequency for procedural/experimental errors. A
variant was defined as a virus that had at least one mutated nucleotide in given sites of the
nucleotide sequence analyzed.
Statistical analyses
Continuous variables (i.e. viral load, variant numbers) were compared using the Mann-Whit-
ney U test for independent non-parametric data. The Spearman rank correlation coefficient
was used for the correlation analysis of non-parametric data. All of the analyses were two
tailed, and performed using GraphPad Prism version 5 (GraphPad Software Inc., CA, USA);
p-values of0.05 were considered statistically significant.
Results
Patients and samples
A total of 150 respiratory samples from 88 patients admitted to ICUs with severe respiratory
syndrome were analyzed. Of these, 90/150 (60.0%) were URT specimens (NS or NPA), while
60/150 (40.0%) were LRT specimens (BAL or Brasp). Sixty-nine out of 88 (78.4%) patients
were positive for a respiratory viral infection, while 19/88 (21.6%) were negative (Fig 1). In
66/69 (95.6%) of the positive episodes, a single virus was observed, while in 3/69 (4.4%) epi-
sodes dual viral infections were detected (Fig 1). Influenza A was the most frequent virus
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observed (57/69, 82.6%). In 41/57 (71.9%) patients, subtype A/H1N1pdm09 (40 single and 1
co-infection) was detected, while in 16/57 (28.1%) patients a subtype A/H3N2 (15 single and 1
co-infection) was detected. HRV was detected in 8/69 (11.6%) patients, RSV in 2/69 (2.9%)
and influenza B in 1/69 (1.4%). In three patients, dual viral infections were observed: influenza
A/H1N1pdm09 and HRV (1 pt), influenza B and RSV (1 pt) and influenza A/H3N2 and hCoV
(1 pt). For a subset of patients (23/88, 26.1%), additional information on bacterial/fungal co-
infections were available. Among them, 2/23 (8.7%) had a coinfections with influenza A/
H1N1pdm09 and Candida spp, 1/23 (4.3%) with A/H1N1pdm09 and Aspergillus spp, 1/23
(4.3%) with influenza A and K. pneumoniae, while 19/23 (82.7%) were negative (data not
shown).
Influenza A/H1N1pdm09 viral load comparison: URT vs LRT
Among the 41 ICU patients, paired samples (URT and LRT) were available for 10 (24.4%),
from 28 (68.3%) only URT specimens were available and from 3 (7.3%) only LRT specimens
were available. The median viral load in LRT samples (n = 13) was higher than that observed
in the URT samples (n = 38) (2.8x106 vs 2.5x104 RNA copies/ml; p<0.05). Similarly, the
median viral load in URT samples of control patients was slightly higher than that observed in
the URT of ICU patients, although this difference did not reach significance (p>0.05). When
restricting the analysis to the 10 ICU patients with paired samples, influenza load was signifi-
cantly higher in LRT secretions (median 9.5x106 RNA copies/ml, range 9x104-3.8x108) com-
pared to URT samples (median 3.9x103 RNA copies/ml, range 0–1.1x109; p<0.05). In
addition, the median Log10 difference between LRT and URT samples was +2.3 Log10 copies/
ml ranging from -2.7 to +7.5 Log10 RNA copies/ml. Interestingly, in two cases, the URT sam-
ples were negative in the presence of high viral load in the LRT.
Phylogenetic and sequence analyses
A total of 51 (36 NS and 13 BAL or Brasp) respiratory samples from 41 H1N1pdm09-positive
ICU patients as well as 21 NS from patients with mild respiratory syndrome were analyzed by
Fig 1. Frequency distribution of respiratory viruses. The absolute number of positive patients is reported
in brackets.
https://doi.org/10.1371/journal.pone.0178926.g001
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both Sanger and NGS sequencing. Complete HA sequencing was performed on baseline sam-
ples from 26/41 (63.4%) ICU and 21/21 (100.0%) control patients. No sequencing data were
obtained in respiratory samples of 15/41 (31.7%) ICU patients due to low viral load. Of these,
14/15 (93.3%) sequence-negative samples were URT specimens. The overall nucleotide iden-
tity between HA sequences from this study and the reference vaccine strain (A/California/07/
2009) ranged from 97.6% to 98.4%. All of the influenza A/H1N1pdm09 strains belonged to
subgroup 6B, as observed worldwide (Fig 2). Subgroup 6B was characterized by constitutional
K163Q, A256T, K283E and E374K polymorphisms. Additional amino acid polymorphisms
were sporadically observed in HA sequences of a few strains. In detail, the A/Pavia/160/2015
strain carried the G39R and S74R changes, A/Pavia/24/2015 strain the S84R change, A/Pavia/
45/2015 the T232I change, A/Pavia/23/2015 the P236T change and A/Pavia/180/2015 the
E283K change.
Among ICU patients, 22/26 (84.6%) influenza-sequenced strains carried the wild-type
222D codon, while four (15.7%) strains carried mixtures at position 222 (Table 1). In detail,
two patients had a mixture of 222D/N/G, one the 222D/N/A mixture and the other 222D/N.
All of these mixtures were only identified in LRT samples.
Influenza A/H1N1pdm09 variant analysis
NGS was used to analyze the dynamic of Influenza A/H1N1pdm09 population in partial HA
region, spanning from 180 to 286 codons. NGS analysis was successfully performed in 31/41
(75.6%) ICU and 21/21 (100.0%) control patients. In 10/41 (31.7%) ICU patients, no NGS
data were obtained for URT samples due to the low viral load. A total of 409072 reads were
obtained with the NGS platform, and the average of amplicons length was 341 nt. A median of
5506 (range 1966–13083) sequence reads were obtained per sample, which allowed detection
and quantification of minority mutations with a cut-off value of 0.50%.
Among ICU patients (n = 41), the number of variants in the LRT samples (median 14,
range 2–30) was significantly higher than that observed in URT samples (median 7, range
2–21; p<0.05)(Fig 3). Similarly, the number of variants observed in URT samples of ICU
patients (median 7, range 2–21) was higher than that observed in URT samples of control
patients (median 4, range 2–16; p<0.05). Among ten patients with paired samples (#1–10 in
Table 1), the number of variants was performed in paired URT and LRT samples for 4/10
(40.0%) patients, while in 6/10 (60.0%) patients it could only be performed in LRT samples,
due to the low viral load in URT samples (Table 1). For three additional patients (#11–13,
Table 1), the number of variants was determined only in LRT samples.
Overall, mutations (G/N/A) at codon 222 were observed in 4/13 (30.8%) LRT samples
(Table 1). In these patients, a number of mixed variants (as also suggested by Sanger mixed
electropherograms) were detected. All H1N1pdm09 strains detected in the URT of ICU
(n = 22) and control (n = 21) patients carried a 222D polymorphism at a 100% frequency.
Only in one patient, did NGS identify a 222A change with a frequency lower than 5.0% in a
LRT sample. Of note, samples in which the NGS analysis identified only a 222D polymorphism
showed an overall lower number of variants (median 9.5, range 2–17 variants) as compared to
samples with mixed variants at position 222 (median 19.5, range 12–30 variants; p<0.05).
Longitudinal analysis in LRT infections
Follow-up LRT samples were collected in a limited number of patients (n = 4). In these cases, a
longitudinal NGS analysis of the viral population was possible. These four patients received
anti-influenza treatment during the analyzed period as reported in Fig 4. At baseline, in 3/4
cases (75.0%), a mixture of mutations at codon 222 was observed (Fig 4). In samples from
Severe influenza A/H1N1pdm09 infections in ICU-admitted patients
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Fig 2. Phylogenetic comparison of influenza A(H1N1)pdm09 HA gene sequences. Reference
sequences of strains circulating in 2009–2015 are presented in italics (GISAID numbers are provided).
Influenza strains of patients with severe infection are reported with a black circle and strains from patients with
a mild infection are reported with a white circle. Bootstrap values are given at nodes, and the scale bar is given
in numbers of substitutions per site.
https://doi.org/10.1371/journal.pone.0178926.g002
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patients #1 and #2, viral load and the number of variants decreased simultaneously and only
the wild-type amino acid (222D) was detected 13 and 8 days after admission. In samples from
patient #3, an initial decrease in viral load and number of variants was associated with the pres-
ence of wild-type amino acid 222D. However, a sudden increase in viral load and number of
variants was associated with the re-emergence of 222A at a low frequency. From patient #4,
only LRT samples at days 6 and 10 after onset of symptoms were available and the decrease in
both viral load and number of variants was not associated with significant changes in the viral
population at position 222.
Discussion
In the present prospective observational study, the incidence of respiratory viruses was investi-
gated in respiratory samples of patients admitted to 16 ICUs during the 2014–2015 influenza
season. Influenza viruses were the most commonly detected pathogens. The second most iden-
tified virus was HRV with a frequency close to 10%, in keeping with a large prospective study
describing the aetiology of community-acquired pneumonia in the US [18]. The clinical rele-
vance of non-influenza viral infections in ICU patients remains controversial [19–21]. How-
ever, the impact of non-influenza viruses appears more important than previously thought;
thus, these viruses should be included in the diagnostic panel [3,22].
Table 1. Distribution of 222 polymorphisms in 10 paired upper and lower respiratory tract samples and 3 lower respiratory samples analyzed with
Sanger and next generation sequencing (NGS).
# Strain Sample FluA load (copies/ml) No. reads 222 polymorphisms No. variants
NGS (%) Sanger
1 A/Pavia/11/2015 NS negative NA - - -
BAL 3.8x107 7566 D (34.59), N (38.53), G (26.88) D/N/G 30
2 A/Pavia/15/2015 NS 5.9x104 3264 D (100) D 7
BAL 1.9x105 4725 D (100) D 17
3 A/Pavia/42/2015 NS 1.8x102 ND LVL - - -
BAL 1.2x108 5593 D (38.98), N (58.1) A (2.91) D/N 12
4 A/Pavia/171/2015 NS 5.2x105 6493 D (100) D 8
BAL 6.4x108 5993 D (100) D 16
5 A/Pavia/180/2015 NS 1.7x108 5155 D (100) D 11
BAL 2.9x105 6463 D (100) D 11
6 A/Pavia/24/2015 NS 7.1x103 ND, LVL - - -
Brasp 1.3x106 7969 D (61.06), N (21.23), G (17.71) D/N/G 21
7 A/Pavia/160/2015 NS negative NA - D -
BAL 5.3x105 7092 D (100) D 8
8 A/Pavia/271/2015 NS 1.0x109 6818 D (100) D 4
Brasp 2.7x109 6847 D (100) D 16
9 A/Pavia/247/2015 NS 4.5x102 ND, LVL - - -
Brasp 9.0x104 4798 D (100) D 3
10 A/Pavia/55/2015 NS 1.1x104 NA - - -
Brasp 1.7x106 5473 D (34.04), N (65.96) D/N 18
11 A/Pavia/25/2015 BAL 5.3x104 428 D (100) D 2
12 A/Pavia/196/2015 BAL 2.8x106 4895 D (100) D 7
13 A/Pavia/267/2015 BAL 1.8x102 ND, LVL - - -
NS, nasal swab; BAL, bronchoalveolar lavage; Brasp, broncho aspirate; NA, not applicable, ND, not done; LVL, low viral load
https://doi.org/10.1371/journal.pone.0178926.t001
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Fig 3. Distribution of the number of variants in both URT and LRT samples of ICU patients and URT
samples of patients with mild respiratory syndrome.
https://doi.org/10.1371/journal.pone.0178926.g003
Fig 4. Frequencies of 222 polymorphisms are displayed as a stacked histogram for four patients with sequential lower
respiratory tract samples. The number of variants observed and the corresponding viral load are reported above each histogram, while
the time after admission and the antiviral treatment period are reported below each histogram. NA, not available.
https://doi.org/10.1371/journal.pone.0178926.g004
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In this study, A/H1N1pdm09 strains outnumbered A/H3N2 at a ratio approaching 3:1 in
patients admitted to ICUs in Northern Italy. This finding is in contrast with the epidemiologi-
cal scenario observed by sentinel sources of the World Health Organization and National
Influenza Center. In fact, a predominance of influenza A/H3N2 strains in Europe [5] and Italy
(http://www.iss.it/binary/fluv/cont/Rapporto_2014_2015.pdf) was observed during the same
period.
Among ICU patients, the median influenza load in LRT samples was significantly higher
than that observed in URT samples in the same patient group, in keeping with our previous
observations [8,10]. The difference between viral loads was more evident in paired samples
where in all cases except one, viral load was higher in the LRT than URT. Interestingly, in
almost 20% of these patients the viral load in the URT was undetectable in the presence of high
viral load in the LRT. It is reasonable to hypothesize that in severe infections, the initial replica-
tion of influenza in the URT is followed by the spread of influenza in the LRT [23]. At ICU
admission, usually several days after the onset of clinical symptoms, the clinical samples are
collected for the laboratory diagnosis. At this moment, the influenza virus might have been
already cleared from the URT by the immune system, while in the LRT the viral shedding per-
sists[23]. Therefore, our findings underline the importance of appropriate sample collection,
especially in patients with severe infection [23,24].
Considering the D222G/N mutations in the HA gene of influenza A/H1N1pdm09 strains,
which are strictly associated with increased clinical severity [9,25–27], in this study, the pres-
ence of polymorphisms at position 222 of A/H1N1pdm09 strains was assessed by both Sanger
and NGS sequencing in patients with severe infections and in patients (not hospitalized) with
a mild respiratory syndrome. All of the A/H1N1pdm09 strains belonged to the influenza clade
circulating in Europe during the period of sample collection [28].
Intra-host viral diversity was assessed using NGS in respiratory samples by determining the
number of H1N1pdm09 variants. Overall, a greater number of H1N1pdm09 virus variants
were observed in the LRT, suggesting different viral kinetic patterns in the URT, as compared
to LRT of patients with severe influenza infections. The 222G/N mutations known to be asso-
ciated with increased clinical severity were observed in 30% of LTR samples of ICU patients.
In URT samples (ICU and control patients) only the wild type 222D polymorphism was
observed. The frequency of 222G/N changes was in keeping with our previous observations
and other reports [8,10,17,29,30]. Although our data confirm the association between 222G/N
mutations and disease severity, over 70% of ICU patients showed no specific HA mutations
among viral populations in the lung. Therefore, it is reasonable to hypothesize that more than
one virulence determinant is involved in severe influenza infections. Nevertheless, in these
patients, comorbidities or per-existing host genetic factors may have contributed to disease
severity [31].
It has been demonstrated both in vitro and in vivo that strains carrying 222D bind α2–6
sialic acid more efficiently, whereas 222G/N strains have broader tropisms for both α2–6 and
α2–3 sialic acids and therefore replicate more efficiently in the LRT [11,12,30]. In keeping with
this finding, in our series, 222G/N populations were observed only in LRT samples. Unfortu-
nately, no information regarding the quasispecies population of the URT could be obtained
due to low virus load. Viral diversity, evaluated in sequential LRT samples, showed several pat-
terns of population evolution. On the basis of these findings and, due to the limited number of
cases, no major conclusions can be drawn on viral population dynamic in the LRT.
This study has some limitations: i) the frequency of different respiratory viruses could be
biased by the role of our center as a reference laboratory for the diagnosis and confirmation of
severe influenza-like illness; ii) the quasispecies analysis focused only on codon 222, while
complete genome sequencing would have provided more exhaustive information and iii) in a
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portion of the ICU patients, only upper respiratory samples were available and therefore the
diagnosis was performed on a partially biased group of samples.
In conclusion, this study showed the presence of mutations associated with increased clini-
cal severity (222G/N) in at least 30% of ICU patients with LRT infections. A great number of
variants and high viral load were observed in the LRT as compared to URT samples. Finally,
intra-host evolution analysis showed the presence of different dynamics of viral population in
the LRT of patients hospitalized in ICU with a severe influenza infection.
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